Androgen deprivation therapy for prostate cancer: friend or foe to the cardiovascular system?

被引：0
|
作者：
Kaiping Zhang
Li Zhang
Zongyao Hao
Chaozhao Liang
机构：
[1] Anhui Medical University,Department of Urology, The First Affiliated Hospital of Anhui Medical University, and Institute of Urology
来源：
World Journal of Urology | 2016年 / 34卷
关键词：
Androgen Deprivation Therapy; GnRH Agonist; Combine Androgen Blockade; Heart Failure Risk; Orchiectomy Group;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：879 / 881
页数：2
相关论文
共 50 条
  • [31] Androgen receptors in early and castration resistant prostate cancer: friend or foe?
    Vassiliki Pelekanou
    George Notas
    Efstathios N. Stathopoulos
    Elias Castanas
    Marilena Kampa
    Hormones, 2013, 12 : 224 - 235
  • [32] Androgen receptors in early and castration resistant prostate cancer: friend or foe?
    Pelekanou, Vassiliki
    Notas, George
    Stathopoulos, Efstathios N.
    Castanas, Elias
    Kampa, Marilena
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2013, 12 (02): : 224 - 235
  • [33] Cardiovascular risk after androgen deprivation therapy for prostate cancer: an Asian perspective
    Teoh, Jeremy Yuen Chun
    Ng, Chi-Fai
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (09) : 1429 - 1435
  • [34] Cardiovascular risk after androgen deprivation therapy for prostate cancer: an Asian perspective
    Jeremy Yuen Chun Teoh
    Chi-Fai Ng
    International Urology and Nephrology, 2016, 48 : 1429 - 1435
  • [35] Does androgen deprivation therapy in men with prostate cancer increase cardiovascular morbidity?
    Steven M Corsello
    Philip W Kantoff
    Nature Clinical Practice Urology, 2008, 5 : 80 - 81
  • [36] Supervised exercise to reduce cardiovascular morbidity of androgen deprivation therapy for prostate cancer
    Wong, William W.
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (01): : 5 - 7
  • [37] Questioning the reality of an increase in cardiovascular mortality with androgen deprivation therapy for prostate cancer?
    Buvat, J.
    BASIC AND CLINICAL ANDROLOGY, 2011, 21 : 227 - 229
  • [38] Re: Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality
    Mongiat-Artus, Pierre
    EUROPEAN UROLOGY, 2008, 53 (06) : 1297 - 1297
  • [39] Risk of Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer Comment
    Kunath, Frank
    Wullich, Bernd
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (02) : 144 - 145
  • [40] Cardiovascular Disease Risk and Androgen Deprivation Therapy in Patients with Localized Prostate Cancer
    Haque, Reina
    Xu, Xiaoqing
    Yood, Marianne Ulcickas
    Cassidy-Bushrow, Andrea E.
    Van den Eeden, Stephen K.
    Potosky, Arnold L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 323 - 324
12345